
Bioquell
Stage
Acq - P2P | AcquiredValuation
$0000Missing: Bioquell's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Bioquell's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Bioquell Patents
Bioquell has filed 10 patents.
The 3 most popular patent topics include:
- Bones of the head and neck
- Bones of the pelvis
- Oil fields

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
3/14/2013 | 2/20/2018 | Surgical instruments, Experimental cancer drugs, Engine technology, Antineoplastic drugs, Fluoroarenes | Grant |
Application Date | 3/14/2013 |
---|---|
Grant Date | 2/20/2018 |
Title | |
Related Topics | Surgical instruments, Experimental cancer drugs, Engine technology, Antineoplastic drugs, Fluoroarenes |
Status | Grant |
Latest Bioquell News
Sep 7, 2021
Facility management provider Sodexo announces an expanded partnership with water, hygiene, and infection prevention solutions and services provider Ecolab Inc. Together, they will deliver a new infection prevention offering for hospitals and healthcare facilities across the U.S. Sodexo’s program, Protecta Plus, provides an additional solution to help reduce the risk of infection with Ecolab’s Bioquell hydrogen peroxide vapor technology. Protecta Plus offers hospitals technology solutions for their specialized disinfection needs. It provides personalized support and fully managed services with dedicated infection prevention specialists. Protecta Plus also supports Sodexo’s foundational Protecta offering, a standardized, integrated environmental infection program. The program is designed for organizations looking to reduce or stabilize hospital-associated infections (HAIs) and keep them low. “We’re excited to add this to the Protecta Plus lineup,” says Brooke Hossfeld, MPH, CIC, MLS (ASCP) CM, infection prevention specialist for Sodexo. “The broad efficacy of a sterilant is great because hospitals face such a wide range of challenges—from typical organisms like MRSA and C.diff, as well as emerging issues such as COVID-19 variants to C. auris—they need to be ready for almost anything.” Bioquell Hydrogen Peroxide Sterilant is an EPA-registered sterilant that uses an automated process to decontaminate enclosed spaces. It reaches all exposed surfaces—including hard-to-reach ceilings, far corners, and open drawers for maximum impact. The proprietary technology is proven effective against even tough organisms, such as bacterial spores. With Bioquell, Sodexo’s Protecta Plus can be implemented within a variety of service models to provide critical aid in the fight against HAIs in different care settings. “Some patients are especially vulnerable to HAIs,” says Kristen Gray, Ecolab area vice president for life sciences. “Having this sterilant technology to kill viruses, spores, fungi, and bacteria where these patients are treated and heal—burn units, cancer centers, operating rooms, children’s hospitals, and ICUs—is something we’re very proud of. We offer options to all types of facilities, with the option for on-site environmental service teams to run this technology or Ecolab experts who can provide onsite turnkey services.” Share:
Bioquell Frequently Asked Questions (FAQ)
Where is Bioquell's headquarters?
Bioquell's headquarters is located at 52 Royce Cl, Andover.
What is Bioquell's latest funding round?
Bioquell's latest funding round is Acq - P2P.
Who are the investors of Bioquell?
Investors of Bioquell include Ecolab.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.